Dr. Zhan Ye is currently an Associate Professor at the University of Kansas Medical Center, where he serves as the Section Director of Transfusion Service and Medical Director of the Blood Bank. Since 2023, Dr. Ye has also served as Medical Director of the Community Blood Center of Greater Kansas City, a New York Blood Center Enterprises division. Dr. Ye is active in clinical transfusion medicine, apheresis practice, and medical education. His research focuses on transfusion safety, patient blood management, blood donation, and new treatments in transfusion and biotherapy. He published 33 scientific and clinical peer-reviewed papers, 14 abstracts, and one book chapter and gave 35 national/international meeting presentations. As a co-investigator, he participates in NIH-funded research on the pathogenesis and treatment of TTP and COVID-associated hypercoagulopathy. He is on the Editorial Board of Frontiers in Immunology and a reviewer for several journals in transfusion medicine and apheresis practice. Dr. Zheng is a physician-scientist passionate about patient care, education, and innovative research. His research focuses on understanding the mechanism of normal and abnormal blood coagulation. His research team has published more than 140 manuscripts in high-quality and peer-reviewed journals. His laboratory has been consistently supported by grants from the National Institute of Heart, Lung, and Blood. He served as associate editor for the Journal of Thrombosis and Haemostasis and continues serving as the associate on three others. Dr. Zheng has been a standing member of the NIH-Hemostasis, Thrombosis, Blood Cells, and Transfusion study section for the past six years.

• 1. Transfusion management of sickle cell disease (SCD) patients2. Transfusion management of Thrombotic Thrombocytopenic Purpura (TTP) patients3. Autoimmune hemolytic anemia management4. Massive transfusion in trauma and non-trauma patients5. Transfusion support for fetus and newborn6. Management of Acute transfusion reactions7. Platelet refractoriness and transfusion management8. Transfusion support for patients with hematopoietic malignancy9. Transfusion support for patients with antiphospholipid syndrome (APS) or heparin-induced thrombocytopenia (HIT) antibodies10. Bloodless Medicine Protocol11. Whole blood usage in trauma and heart surgery patients12. Pathogen-reduced (PR) platelets and cold-stored platelets13. Difficulties in serologic testing14. Blood shortage management and disaster preparation in Blood Bank15. Look-back investigation in Transfusion Service16. Management of clinical and technical difficulties of apheresis treatment17.Management of refractory life-threatening intoxication by apheresis treatment18. Apheresis support for solid organ transplant and hematopoietic stem cell transplant (HSCT) patients

Dr. Zhan Ye is currently an Associate Professor at the University of Kansas Medical Center, where he serves as the Section Director of Transfusion Service and Medical Director of the Blood Bank. Since 2023, Dr. Ye has also served as Medical Director of the Community Blood Center of Greater Kansas City, a New York Blood Center Enterprises division. Dr. Ye is active in clinical transfusion medicine, apheresis practice, and medical education. His research focuses on transfusion safety, patient blood management, blood donation, and new treatments in transfusion and biotherapy. He published 33 scientific and clinical peer-reviewed papers, 14 abstracts, and one book chapter and gave 35 national/international meeting presentations. As a co-investigator, he participates in NIH-funded research on the pathogenesis and treatment of TTP and COVID-associated hypercoagulopathy. He is on the Editorial Board of Frontiers in Immunology and a reviewer for several journals in transfusion medicine and apheresis practice. Dr. Zheng is a physician-scientist passionate about patient care, education, and innovative research. His research focuses on understanding the mechanism of normal and abnormal blood coagulation. His research team has published more than 140 manuscripts in high-quality and peer-reviewed journals. His laboratory has been consistently supported by grants from the National Institute of Heart, Lung, and Blood. He served as associate editor for the Journal of Thrombosis and Haemostasis and continues serving as the associate on three others. Dr. Zheng has been a standing member of the NIH-Hemostasis, Thrombosis, Blood Cells, and Transfusion study section for the past six years.

• 1. Transfusion management of sickle cell disease (SCD) patients2. Transfusion management of Thrombotic Thrombocytopenic Purpura (TTP) patients3. Autoimmune hemolytic anemia management4. Massive transfusion in trauma and non-trauma patients5. Transfusion support for fetus and newborn6. Management of Acute transfusion reactions7. Platelet refractoriness and transfusion management8. Transfusion support for patients with hematopoietic malignancy9. Transfusion support for patients with antiphospholipid syndrome (APS) or heparin-induced thrombocytopenia (HIT) antibodies10. Bloodless Medicine Protocol11. Whole blood usage in trauma and heart surgery patients12. Pathogen-reduced (PR) platelets and cold-stored platelets13. Difficulties in serologic testing14. Blood shortage management and disaster preparation in Blood Bank15. Look-back investigation in Transfusion Service16. Management of clinical and technical difficulties of apheresis treatment17.Management of refractory life-threatening intoxication by apheresis treatment18. Apheresis support for solid organ transplant and hematopoietic stem cell transplant (HSCT) patients

Dr. Zhan Ye is currently an Associate Professor at the University of Kansas Medical Center, where he serves as the Section Director of Transfusion Service and Medical Director of the Blood Bank. Since 2023, Dr. Ye has also served as Medical Director of the Community Blood Center of Greater Kansas City, a New York Blood Center Enterprises division. Dr. Ye is active in clinical transfusion medicine, apheresis practice, and medical education. His research focuses on transfusion safety, patient blood management, blood donation, and new treatments in transfusion and biotherapy. He published 33 scientific and clinical peer-reviewed papers, 14 abstracts, and one book chapter and gave 35 national/international meeting presentations. As a co-investigator, he participates in NIH-funded research on the pathogenesis and treatment of TTP and COVID-associated hypercoagulopathy. He is on the Editorial Board of Frontiers in Immunology and a reviewer for several journals in transfusion medicine and apheresis practice. Dr. Zheng is a physician-scientist passionate about patient care, education, and innovative research. His research focuses on understanding the mechanism of normal and abnormal blood coagulation. His research team has published more than 140 manuscripts in high-quality and peer-reviewed journals. His laboratory has been consistently supported by grants from the National Institute of Heart, Lung, and Blood. He served as associate editor for the Journal of Thrombosis and Haemostasis and continues serving as the associate on three others. Dr. Zheng has been a standing member of the NIH-Hemostasis, Thrombosis, Blood Cells, and Transfusion study section for the past six years.

• 1. Transfusion management of sickle cell disease (SCD) patients2. Transfusion management of Thrombotic Thrombocytopenic Purpura (TTP) patients3. Autoimmune hemolytic anemia management4. Massive transfusion in trauma and non-trauma patients5. Transfusion support for fetus and newborn6. Management of Acute transfusion reactions7. Platelet refractoriness and transfusion management8. Transfusion support for patients with hematopoietic malignancy9. Transfusion support for patients with antiphospholipid syndrome (APS) or heparin-induced thrombocytopenia (HIT) antibodies10. Bloodless Medicine Protocol11. Whole blood usage in trauma and heart surgery patients12. Pathogen-reduced (PR) platelets and cold-stored platelets13. Difficulties in serologic testing14. Blood shortage management and disaster preparation in Blood Bank15. Look-back investigation in Transfusion Service16. Management of clinical and technical difficulties of apheresis treatment17.Management of refractory life-threatening intoxication by apheresis treatment18. Apheresis support for solid organ transplant and hematopoietic stem cell transplant (HSCT) patients